Clinical Research Directory
Browse clinical research sites, groups, and studies.
ASSIST: Treatment for Childhood Apraxia of Speech
Sponsor: Temple University
Summary
Childhood apraxia of speech (CAS) is a pediatric motor speech disorder that impairs the planning of movements needed for intelligible speech. Children with CAS often show little or slow progress in standard speech therapy. This research is a Phase 1 study that tests initial efficacy and optimal parameters of a theoretically based integral stimulation treatment called ASSIST (Apraxia of Speech Systematic Integral Stimulation Treatment). In four small randomized group design studies across three recruitment cycles (N=20 per cycle), children receive 16 hours of individual ASSIST. The studies systematically investigate the effect of treatment (ASSIST vs. no ASSIST; Study 1), the effect of complexity (complex vs. simple utterances; Study 2), the effect of lexicality (word vs. nonword targets; Study 3), and the effect of treatment intensity (Massed vs. Distributed ASSIST; Study 4). Studies 1 and 4 also systematically examine the effect of treatment on functional outcome measures, including parent ratings of intelligibility and communicative participation, and objective intelligibility measures obtained from unfamiliar listeners.
Official title: ASSIST: Child Apraxia Speech Treatment
Key Details
Gender
All
Age Range
4 Years - 9 Years
Study Type
INTERVENTIONAL
Enrollment
51
Start Date
2019-04-18
Completion Date
2025-11-30
Last Updated
2026-05-22
Healthy Volunteers
Yes
Conditions
Interventions
ASSIST
Integral stimulation based treatment ("watch me, listen to me, say what I say") for CAS that is based on principles of motor learning and neuroplasticity and includes a systematic approach to adaptive practice. Treatment includes a focus on prosody, use of visual, tactile, auditory cues, slowing speech rate, and large amounts of practice.
Locations (1)
Temple University
Philadelphia, Pennsylvania, United States